| Baseline | 3 Months | 6 Months | 12 months | Country | Instrument | Source |
---|---|---|---|---|---|---|---|
CKD stage 2 | NR | Â | Â | Â | Â | Â | Â |
CKD stage 3 | 0.67 (0.30) | Â | 0.67 (0.29) | Â | UK | EQ-5D-3L | [29] |
CKD stage 3a | NR | Â | Â | Â | Â | Â | Â |
CKD stage 3b | NR | Â | Â | Â | Â | Â | Â |
CKD stage 4 | NR | Â | Â | Â | Â | Â | Â |
CKD stage 5 | NR | Â | Â | Â | Â | Â | Â |
Haemodialysis | 0.65 (0.027) | Â | Â | 0.62 (0.030) | Canada | EQ-5D-3L | [30] |
Peritoneal dialysis | 0.64 (0.063) | Â | Â | 0.67 (0.046) | Canada | EQ-5D-3L | [30] |
Transplant | Pre-Transplant | Post-Transplant | |||||
0.74 (0.21) | 0.81 (0.19) | 1.0 (0) | 0.82 (0.20) | Spain | EQ-5D-3L | [31] | |
0.61 (NR) | Â | Â | 0.74 (NR) | USA | EQ-5D-3L | [32] | |
0.78 (NR) | Â | Â | 0.86 (NR) | USA | EQ-5D-3L | [32] |